Novel longitudinal Multiple Overall Toxicity (MOTox) score to quantify adverse events experienced by patients during chemotherapy treatment: a retrospective analysis of the MRC BO06 trial in osteosarcoma

OBJECTIVES: This study aims at exploring and quantifying multiple types of adverse events (AEs) experienced by patients during cancer treatment. A novel longitudinal score to evaluate the Multiple Overall Toxicity (MOTox) burden is proposed. The MOTox approach investigates the personalised evolution...

Descripción completa

Detalles Bibliográficos
Autores principales: Spreafico, Marta, Ieva, Francesca, Arlati, Francesca, Capello, Federico, Fatone, Federico, Fedeli, Filippo, Genalti, Gianmarco, Anninga, Jakob, Gelderblom, Hans, Fiocco, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Research Methods
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679129/
https://www.ncbi.nlm.nih.gov/pubmed/34916320
http://dx.doi.org/10.1136/bmjopen-2021-053456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679129/
https://www.ncbi.nlm.nih.gov/pubmed/34916320
http://dx.doi.org/10.1136/bmjopen-2021-053456

Ejemplares similares